114 related articles for article (PubMed ID: 38031398)
1. Gastric Carcinoma with low ROR alpha, low E- Cadherin and High LAPTM4B Immunohistochemical Profile; is associated with unfavorable prognosis in Egyptian patients.
El Mashad SN; Kandil MAEH; Talab TAE; Saied Abd El Naby AEN; Sultan MM; Sohaib A; Hemida AS
J Immunoassay Immunochem; 2024 Jan; 45(1):50-72. PubMed ID: 38031398
[TBL] [Abstract][Full Text] [Related]
2. Lysosomal-associated protein transmembrane 4 Beta-35 overexpression is a novel independent prognostic marker for gastric carcinoma.
Liu L; Xu X; Jing L; Zhou G; Cao Z; Han Y; Zhou R
PLoS One; 2015; 10(2):e0118026. PubMed ID: 25689860
[TBL] [Abstract][Full Text] [Related]
3. LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro.
Xiao M; Yang S; Meng F; Qin Y; Yang Y; Jia S; Cai X; Li C; Huang Y; Ning X
Cell Physiol Biochem; 2017; 41(3):1072-1082. PubMed ID: 28245476
[TBL] [Abstract][Full Text] [Related]
4. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.
Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF
PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori infection promotes epithelial-to-mesenchymal transition of gastric cells by upregulating LAPTM4B.
Zhou S; Chen H; Yuan P; Shi N; Wang X; Hu J; Liu L
Biochem Biophys Res Commun; 2019 Jun; 514(3):893-900. PubMed ID: 31084933
[TBL] [Abstract][Full Text] [Related]
6. Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma.
Li Y; Chen CQ; He YL; Cai SR; Yang DJ; He WL; Xu JB; Zan WH
J Surg Oncol; 2012 Sep; 106(3):304-10. PubMed ID: 22231933
[TBL] [Abstract][Full Text] [Related]
7. The immunohistochemical expression of E-cadherin in gastric cancer; correlations with clinicopathological factors and patients' survival.
Lazăr D; Tăban S; Ardeleanu C; Dema A; Sporea I; Cornianu M; Lazăr E; Vernic C
Rom J Morphol Embryol; 2008; 49(4):459-67. PubMed ID: 19050793
[TBL] [Abstract][Full Text] [Related]
8. LAPTM4B-35 protein as a potential therapeutic target in gastric cancer.
Zhang H; Tian B; Yu H; Yao H; Gao Z
Tumour Biol; 2014 Dec; 35(12):12737-42. PubMed ID: 25416438
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin in gastric carcinomas: Relations with histological parameters and its prognostic value.
Schizas D; Moris D; Michalinos A; Kanavidis P; Oikonomou D; Papalampros A; Machairas A; Liakakos T
J BUON; 2017; 22(2):383-389. PubMed ID: 28534359
[TBL] [Abstract][Full Text] [Related]
10. The expressions and prognostic implications of Twist and E-cadherin in adenocarcinomas of the gastroesophageal junction and proximal gastric carcinoma.
Sun S; Gong Q
Medicine (Baltimore); 2019 Dec; 98(52):e18449. PubMed ID: 31876727
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of LKB1 is associated with epithelial-mesenchymal transition and led to an unfavorable prognosis in gastric cancer.
Hu M; Zhao T; Liu J; Zou Z; Xu Q; Gong P; Guo H
Hum Pathol; 2019 Jan; 83():133-139. PubMed ID: 30171989
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin in gastric carcinomas related to histological prognostic parameters.
Stănculescu D; Mărgăritescu C; Stepan A; Mitruţ AO
Rom J Morphol Embryol; 2011; 52(3 Suppl):1107-12. PubMed ID: 22119833
[TBL] [Abstract][Full Text] [Related]
13. Modulation of E-cadherin by hepatocyte growth factor induces aggressiveness of gastric carcinoma.
Han SU; Lee HY; Lee JH; Kim WH; Nam H; Kim H; Cho YK; Kim MW; Lee KU
Ann Surg; 2005 Nov; 242(5):676-83. PubMed ID: 16244541
[TBL] [Abstract][Full Text] [Related]
14. [CircPCSK5 is highly expressed in gastric cancer and promotes cancer cell proliferation, invasion and epithelial-mesenchymal transition].
Zuo X; Cai J; Chen Z; Li Y; Zhang D
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1440-1451. PubMed ID: 36329577
[TBL] [Abstract][Full Text] [Related]
15. Long Non-Coding RNA RP11-789C1.1 Suppresses Epithelial to Mesenchymal Transition in Gastric Cancer Through the RP11-789C1.1/MiR-5003/E-Cadherin Axis.
Chen Z; Wu J; Huang W; Peng J; Ye J; Yang L; Yuan Y; Chen C; Zhang C; Cai S; He Y; Wu S; Song W
Cell Physiol Biochem; 2018; 47(6):2432-2444. PubMed ID: 29991048
[TBL] [Abstract][Full Text] [Related]
16. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.
Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL
J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886
[TBL] [Abstract][Full Text] [Related]
17. RORα and REV-ERBα are Associated With Clinicopathological Parameters and are Independent Biomarkers of Prognosis in Gastric Cancer.
Wang X; Jia R; Chen K; Wang J; Jiang K; Wang Z
Technol Cancer Res Treat; 2021; 20():15330338211039670. PubMed ID: 34931925
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of LAPTM4B-35 is a negative prognostic factor in head and neck squamous cell carcinoma.
Kotowski U; Kadletz L; Schneider S; Oberndorfer F; Schnoell J; Gurnhofer E; Kenner L; Lucas T; Heiduschka G
Sci Rep; 2019 Dec; 9(1):18866. PubMed ID: 31827181
[TBL] [Abstract][Full Text] [Related]
19. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.
Wang YG; Xu L; Jia RR; Wu Q; Wang T; Wei J; Ma JL; Shi M; Li ZS
Dig Dis Sci; 2016 Aug; 61(8):2272-2283. PubMed ID: 27010547
[TBL] [Abstract][Full Text] [Related]
20. RORα Suppresses Epithelial-to-Mesenchymal Transition and Invasion in Human Gastric Cancer Cells via the Wnt/β-Catenin Pathway.
Su J; Su B; Xia H; Liu F; Zhao X; Li J; Zhang J; Shi Y; Zeng Y; Zeng X; Ling H; Wu Y; Su Q
Front Oncol; 2019; 9():1344. PubMed ID: 31867273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
